 "Panacea Biotech Q1 net loss at Rs 61 cr")
The company had reported net loss of Rs 65.97 crore in the April-June quarter of the last fiscal.
Panacea Biotech's net sales in Q1, 2013-14 were at Rs 104.46 crore, an increase of 25.70% as against Rs 83.10 crore in the year-ago period, the company said in BSE filing.
More From This Section
Revenue from vaccines in Q1 grew over four fold at Rs 28.04 crore, and revenue from formulations was at Rs 81.58 crore down 0.22%.
Overall expenses in the quarter were at Rs 145.72 crore, an increase of 14.43% compared with Rs 127.34 crore in the corresponding period last year.
Panacea Biotech scrip closed at Rs 94.50, up 3%, on the BSE.